Skip to content

Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario

Bridging the Gap: Incorporating Exercise Evidence Into Clinical Practice in Breast Cancer Care in Ontario

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03087461
Enrollment
26
Registered
2017-03-22
Start date
2017-06-01
Completion date
2018-10-01
Last updated
2019-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Breast cancer (BC) and its treatments lead to numerous side effects that affect a person's life for years after treatment has ended. Research shows that regular exercise limits many of these side effects. However, less than 30% of BC survivors regularly exercise due to many barriers that include patients being unaware of the benefits of exercise, health professionals facing institutional, personal, and patient-related barriers to promoting exercise, and a lack of knowledge translation (KT) strategies within cancer institutions that focus on accessible exercise interventions and education by physiotherapists. For this project, a pilot study is needed as the first step in order to assess process and resource variables before implementation of a large-scale intervention. The primary objective of this pilot trial is to assess the feasibility of conducting a larger trial to evaluate the effects of a novel KT intervention using exercise and self-management versus usual care among BC survivors. The secondary objective is to determine preliminary estimates of effects of the KT intervention of exercise plus self-management (SM) program versus usual care on (a) levels of exercise knowledge and behaviour, (b) health related quality of life and (c) resource utilization, among BC survivors over a four month period.

Detailed description

Study Design: Pilot randomized controlled trial. Eligibility: Women older than 18 years who are currently undergoing chemotherapy treatment for BC. Intervention: The intervention group includes an 8-session multi-component intervention with a structured aerobic exercise program plus SM supervised by a physiotherapist. Setting: Outpatient-Juravinski Cancer Centre in Hamilton, ON. Control: Usual care. Randomization: Participants will be randomly allocated using a 1:1 allocation ratio to receive the intervention of structured exercise plus SM program or usual care. Sample size: The study will recruit n=12 number of participants/group for a total of 24 in both groups. Analysis: A blinded assessor will assess outcomes at baseline, post intervention, at 2- and 4-month follow up. Intervention feasibility and effectiveness will be assessed using descriptive statistics and analysis of covariance for continuous outcomes. Anticipated Impact: This study aims to assess the feasibility of a larger trial to determine effective ways to close the current KT gap and increase exercise awareness for women with BC. This project will assess process and resource variables before implementation of a larger scale intervention. Together, the overall project goal is to promote sustainable exercise behaviour to help manage the burden of BC.

Interventions

BEHAVIORALExercise and self-management

The intervention will include aerobic exercise and self-management education using technology.

Sponsors

Hamilton Health Sciences Corporation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Community-dwelling, English-speaking women, over 18 years, who are currently undergoing chemotherapy for Stage 1-3 BC and have been cleared by their oncologist to participate in moderate intensity aerobic exercise

Exclusion criteria

* Participants will be excluded from the study if they have another chronic disease, cognitive impairment or injury that prevents them from participating independently in moderate intensity exercise

Design outcomes

Primary

MeasureTime frameDescription
Study Recruitment Rate: percentage of eligible patients recruitedBaselineA recruitment log will be kept, detailing reasons for non-participation.
Intervention Retention Rate: percentage of consented participants who completed the interventionPost-intervention (2 months post baseline)Attendance will be tracked on the feasibility data collection sheet and reasons for non-participation on scheduled intervention days will be documented using an adherence log
Intervention Adherence Rate: percentage of total intervention sessions attendedPost-intervention (2 months post baseline)Attendance will be tracked on the feasibility data collection sheet and reasons for non-participation on scheduled intervention days will be documented using an adherence log

Secondary

MeasureTime frameDescription
Health statusBaseline, post intervention (2 months post baseline), 2 and 4 month follow up (post intervention completion)European Quality of Life-Five Dimension (EQ-5D)
Health related quality of lifeBaseline, post intervention (2 months post baseline), 2 and 4 month follow up (post intervention completion)Functional Assessment of Cancer Therapy-Breast
Physical Activity LevelBaseline, post intervention, 2 and 4 month follow upGodin Leisure Time Physical Activity Questionnaire
Use of health care servicesBaseline, post intervention (2 months post baseline), 2 and 4 month follow up (post intervention completion)Piloted form assessing doctor visits, procedures, medication use, missed days of work
Exercise knowledgeBaseline, post intervention (2 months post baseline), 2 and 4 month follow up (post intervention completion)Theory of planned behaviour questionnaire
Exercise behaviourBaseline, post intervention (2 months post baseline), 2 and 4 month follow up (post intervention completion)Theory of planned behaviour questionnaire

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026